Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-13

FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lithium Carbonate by Rising Pharma Holdings, Inc., updating the approved labeling/indication framework under the dru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE (LITHIUM CARBONATE)